Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer - Kaufmann, S; Bedke, J; Gatidis, S (World J Urol, 2016)